Medline ® Abstract for Reference 68
of 'Neuroleptic malignant syndrome'
68
TI
The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?
AU
Rosebush PI, Stewart T, Mazurek MF
SO
Br J Psychiatry. 1991;159:709.
In a prospective study of 20 patients with NMS, those who received dantrolene (2 patients) or bromocriptine (2 patients) or both (4 patients) tended to have a more prolonged course of illness and a greater incidence of sequelae than those treated with supportive care alone. These results do not indicate a useful role for dantrolene or bromocriptine in the treatment of NMS.
AD
Department of Psychiatry, McMaster University Medical Centre, Hamilton, Ontario, Canada.
PMID